CBS Shifts to Hunt for Next CEO

Tom Staggs, the former operating chief of Walt Disney, has emerged as a top candidate for the chief executive job at CBS, as the network looks to turn the page on months of uncertainty and upheaval since the departure of Leslie Moonves.

 
CVS Urges Judge Not to Halt Integration of Aetna

A federal judge softened his previous suggestion that he would likely issue a court order requiring CVS Health to halt its integration of newly acquired insurer Aetna, citing CVS's pledges to keep certain aspects of Aetna's operations separate for now.

 
FedEx Starts Buyout Program as Express Struggles

The delivery carrier says it expects a pretax charge of up to $575 million from the buyout plan and that it intends to cut international capacity at FedEx Express, where performance has weakened.

 
Conagra Finds New Buyer for Wesson

Canadian agribusiness firm Richardson International has agreed to buy the cooking-oil brand, as Conagra refocuses its business on frozen meals and foods.

 
Rice Brothers Seek CEO Post, Board Shakeup at EQT

Toby and Derek Rice, who sold Rice Energy to EQT, have also gained support of activist shareholder Elliott Management.

 
Volkswagen Supplier to Pay $35 Million Fine in Emissions-Cheating Probe

IAV, a Volkswagen supplier, has agreed to plead guilty and pay a $35 million fine for its role in the German auto giant's emissions-cheating scheme.

 
Regulator Fines Glencore Copper Unit $21.3 Million

Canada's main stock-market regulator issued a record $21.3 million fine to a Glencore-controlled copper-mining company to settle allegations that it misled investors.

 
EQT, KKR Among Potential Bidders for Long Beach Container Terminal

Global investors including EQT Partners and KKR & Co. are looking at bidding for the Long Beach Container Terminal in Southern California, as are seasoned ship operators Seaspan and Hyundai Merchant Marine.

 
Darden Says Diners Are Trading Up Amid Strong Labor Market

A strong labor market is pushing diners at Darden's restaurant chains to splurge, helping overcome weaker traffic at Olive Garden during its latest quarter.

 
Big Pharma Wins Drug Approval in China Ahead of West for First Time

China has approved AstraZeneca and Fibrogen's new anemia drug roxadustat, marking the first time a medicine from a global pharmaceutical company has received the green light there before any other market.

(END) Dow Jones Newswires

December 18, 2018 23:00 ET (04:00 GMT)

Copyright (c) 2018 Dow Jones & Company, Inc.